| MeSH term | MeSH ID | Detail |
|---|---|---|
| Weight Loss | D015431 | 56 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Koch FP et al. | Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. | 2012 | Clin Oral Investig | pmid:20938793 |
| Xiang G et al. | Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. | 2012 | Exp. Clin. Endocrinol. Diabetes | pmid:23070830 |
| Wang D et al. | Accelerated calvarial healing in mice lacking Toll-like receptor 4. | 2012 | PLoS ONE | pmid:23071670 |
| Koole D et al. | Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. | 2012 | Arterioscler. Thromb. Vasc. Biol. | pmid:22516062 |
| Rattazzi M et al. | Osteoprotegerin levels are increased in patients with venous thromboembolic disease. | 2012 | J. Thromb. Haemost. | pmid:22486966 |
| Ozkok A et al. | Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. | 2012 | Clin J Am Soc Nephrol | pmid:22490874 |
| Funck-Brentano T et al. | Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. | 2012 | PLoS ONE | pmid:22432033 |
| Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
| Al-Sabbagh M et al. | Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. | 2012 | J. Periodont. Res. | pmid:22126530 |
| Talib A et al. | The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. | 2012 | Hypertens. Res. | pmid:22129515 |
| Liang D et al. | Zinc upregulates the expression of osteoprotegerin in mouse osteoblasts MC3T3-E1 through PKC/MAPK pathways. | 2012 | Biol Trace Elem Res | pmid:22081405 |
| GarcÃa-Hernández A et al. | High glucose concentrations alter the biomineralization process in human osteoblastic cells. | 2012 | Bone | pmid:22086137 |
| Kühn MC et al. | Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. | 2012 | Mol. Cell. Endocrinol. | pmid:22040599 |
| Pineda B et al. | Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. | 2012 | Menopause | pmid:22067277 |
| Chuang FH et al. | Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions. | 2012 | J. Oral Pathol. Med. | pmid:21793936 |
| Rodriguez-Lorenzo LM et al. | Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. | 2012 | J Tissue Eng Regen Med | pmid:21800433 |
| Güncü GN et al. | Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. | 2012 | Cytokine | pmid:22592038 |
| Helo S et al. | Role of denosumab in prostate cancer. | 2012 | Prostate Cancer Prostatic Dis. | pmid:22370723 |
| Røysland R et al. | Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. | 2012 | Heart | pmid:22373720 |
| Brambila-Tapia AJ et al. | MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. | 2012 | Dis. Markers | pmid:22377704 |
| Gimenez-Maitre A et al. | Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis. | 2012 | Eur. Respir. J. | pmid:22379154 |
| Mao X et al. | Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. | 2012 | Inflammation | pmid:22391745 |
| Kim H et al. | Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. | 2012 | Arch. Gynecol. Obstet. | pmid:22392486 |
| Liu S et al. | Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. | 2012 | Hum. Cell | pmid:22399266 |
| Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
| Zupan J et al. | The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. | 2012 | J. Biomed. Sci. | pmid:22380539 |
| Santos VR et al. | Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. | 2012 | J. Periodont. Res. | pmid:21806617 |
| Kanbe K et al. | Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis. | 2012 | Rheumatol. Int. | pmid:21789615 |
| Nonaka CF et al. | Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. | 2012 | Arch. Oral Biol. | pmid:21871606 |
| Zheleznyak A et al. | Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. | 2012 | Mol Imaging Biol | pmid:21853370 |
| Dorota DK et al. | The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. | 2012 | Hypertens Pregnancy | pmid:20822429 |
| Dickerson TJ et al. | Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. | 2012 | J. Autoimmun. | pmid:22867712 |
| Chao TH et al. | Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwanese women. | 2012 | J Chin Med Assoc | pmid:22824048 |
| Wang Y et al. | Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. | 2012 | Connect. Tissue Res. | pmid:22827452 |
| Zhou WJ et al. | [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. | 2012 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:22883830 |
| Mayahara K et al. | Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). | 2012 | Arch. Oral Biol. | pmid:22884709 |
| Hosbond SE et al. | Osteoprotegerin as a marker of atherosclerosis: a systematic update. | 2012 | Scand. Cardiovasc. J. | pmid:22506827 |
| Korzon-Burakowska A et al. | Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. | 2012 | Diabet. Med. | pmid:21913967 |
| Li YF et al. | The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. | 2012 | Osteoporos Int | pmid:21892678 |
| Ohe JY et al. | Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. | 2012 | Clin Oral Investig | pmid:21938481 |
| Bloch SL et al. | The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. | 2012 | Anat Rec (Hoboken) | pmid:22577084 |
| Tsubaki M et al. | Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. | 2012 | Mol. Cell. Endocrinol. | pmid:22579611 |
| Wang YD et al. | Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway. | 2012 | Chin. Med. J. | pmid:22613593 |
| Ma Y et al. | Effects of brucine on bone metabolism in multiple myeloma. | 2012 | Mol Med Rep | pmid:22614932 |
| Ma D et al. | Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. | 2012 | J. Proteome Res. | pmid:22616666 |
| Kim EC et al. | Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. | 2012 | J Endod | pmid:22595110 |
| da Silva RA et al. | Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. | 2012 | J Endod | pmid:22595116 |
| Chen WH et al. | Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. | 2012 | Chin J Integr Med | pmid:22549392 |
| Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
| Wang YD et al. | Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. | 2012 | Horm. Metab. Res. | pmid:22556124 |
| Shuid AN et al. | Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. | 2012 | BMC Complement Altern Med | pmid:22967165 |
| Fichna M et al. | Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. | 2012 | J. Physiol. Pharmacol. | pmid:23388484 |
| Torchinsky A et al. | Bone loss in adult offspring induced by low-dose exposure to teratogens. | 2012 | J. Bone Miner. Metab. | pmid:21960178 |
| Hou JM et al. | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22902986 |
| Ma B et al. | Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22426695 |
| Schweikle E et al. | Osteoprotegerin positively regulates hematopoietic progenitor cells. | 2012 | Curr Stem Cell Res Ther | pmid:22023625 |
| GarcÃa-MartÃn A et al. | [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. | 2012 | Med Clin (Barc) | pmid:22024564 |
| Zijlstra WP et al. | Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. | 2012 | J. Orthop. Res. | pmid:22025323 |
| Zhao N et al. | Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. | 2012 | Orthod Craniofac Res | pmid:22264323 |
| Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
| Rimondi E et al. | Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. | 2012 | Invest New Drugs | pmid:21541705 |
| Tibullo D et al. | Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors. | 2012 | Hematol Oncol | pmid:21544849 |
| Gradosova I et al. | Protective effect of amlodipine on rat bone tissue after orchidectomy. | 2012 | Pharmacology | pmid:22302040 |
| Kennedy OD et al. | Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. | 2012 | Bone | pmid:22342796 |
| Leistner DM et al. | Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. | 2012 | Circ Heart Fail | pmid:22936827 |
| Liu T et al. | [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230665 |
| Li L et al. | [Progress of osteogenic effect of strontium and its application in orthopaedics]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230680 |
| Qiu S et al. | [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. | 2012 | Yao Xue Xue Bao | pmid:22993856 |
| Vik A et al. | Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. | 2012 | Thromb. Res. | pmid:22909822 |
| Dong W et al. | [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. | 2012 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:23268391 |
| Feng Y et al. | AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. | 2012 | Chin. Med. J. | pmid:22964327 |
| Pedersen S et al. | Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. | 2012 | Cardiology | pmid:22964478 |
| Kadkhodazadeh M et al. | Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. | 2012 | Eur J Oral Implantol | pmid:23304691 |
| Curl L et al. | A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. | 2012 | Aust Orthod J | pmid:23304971 |
| Emanuele E et al. | Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. | 2012 | Front Biosci (Elite Ed) | pmid:22201906 |
| Karatolios K et al. | Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. | 2012 | Clin. Biochem. | pmid:22202560 |
| Delgado-Calle J et al. | Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. | 2012 | Epigenetics | pmid:22207352 |
| Bao L et al. | Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model. | 2012 | Joint Bone Spine | pmid:22154615 |
| Shahnazari M et al. | Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. | 2012 | Bone | pmid:22154841 |
| Zheng CM et al. | Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. | 2012 | Tohoku J. Exp. Med. | pmid:22156488 |
| Said F et al. | The effect of etidronate on the periodontium of ovariectomized rats. | 2012 | J. Periodontol. | pmid:22166164 |
| Guo D et al. | Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. | 2012 | Mol. Cell. Biochem. | pmid:22167620 |
| Svensson M et al. | Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. | 2012 | Nephrol. Dial. Transplant. | pmid:22172725 |
| Kraus D et al. | Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. | 2012 | Clin Oral Investig | pmid:22186940 |
| Upton AR et al. | The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. | 2012 | Rheumatol. Int. | pmid:21259010 |
| Miyaji Y et al. | Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. | 2012 | Pharm. Res. | pmid:22729371 |
| Khoury N et al. | Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22730513 |
| Oue E et al. | CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22771802 |
| Bilgin E et al. | Markers of bone metastases in breast and lung cancers. | 2012 | Asian Pac. J. Cancer Prev. | pmid:23167338 |
| Luo ZR and Xie QJ | [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. | 2012 | Zhongguo Wei Zhong Bing Ji Jiu Yi Xue | pmid:23168201 |
| Cui L et al. | Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte. | 2012 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:22776650 |
| Li YL and Wang H | [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. | 2012 | Zhongguo Dang Dai Er Ke Za Zhi | pmid:22989431 |
| Tyagi AM et al. | Formononetin reverses established osteopenia in adult ovariectomized rats. | 2012 | Menopause | pmid:22781783 |
| Kim IS et al. | Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. | 2012 | J. Dent. Res. | pmid:23086742 |
| Xu Y et al. | [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803436 |
| Zhu XF et al. | [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803437 |
| Davenport C et al. | The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. | 2012 | Eur. J. Clin. Invest. | pmid:22803952 |
| Mirzaei K et al. | Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. | 2012 | Minerva Med. | pmid:22805623 |
| Zhou W et al. | [Expression of receptor activator nuclear factor kappa B ligand and osteoprotegerin in peri-implant soft tissue and bone tissue]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22389960 |
| Belibasakis GN and Bostanci N | The RANKL-OPG system in clinical periodontology. | 2012 | J. Clin. Periodontol. | pmid:22092994 |